Literature DB >> 31215581

The role of olefin geometry in the activity of hydrocarbon stapled peptides targeting eukaryotic translation initiation factor 4E (eIF4E).

James M Song1, Erin E Gallagher2, Arya Menon2, Lauren D Mishra2, Amanda L Garner3.   

Abstract

Hydrocarbon stapled (HCS) peptides are a class of cross-linked α-helix mimetics. The technology relies on the use of α,α'-disubstituted alkenyl amino acids, which fully contrain the helical region to typically yield peptides with enhanced structural ordering and biological activity. Recently, monosubstituted alkenyl amino acids were disclosed for peptide stapling; however, the impact that this tether has on HCS peptide structure and activity has not yet been fully explored. By applying this HCS to the disordered peptide eIF4E-binding protein 1 (4E-BP1), we discovered that this type of tethering has a dramatic effect on olefin geometry and activity of the resultant stapled peptides, where the putative trans isomer was found to exhibit enhanced in vitro and cellular inhibitory activity against eIF4E protein-protein interactions. We further demonstrated that the metathesis catalyst used for ring-closing metathesis can influence monosubstituted HCS peptide activity, presumably through alteration of the cis/trans olefin ratio. This study represents one of the first in-depth analyses of olefin isomers of a stapled peptide and highlights an additional feature for medicinal chemistry optimization of this class of peptide-based probes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31215581      PMCID: PMC6625666          DOI: 10.1039/c9ob01041f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  37 in total

1.  A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA.

Authors:  N Sonenberg; M A Morgan; W C Merrick; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  4E binding proteins inhibit the translation factor eIF4E without folded structure.

Authors:  C M Fletcher; A M McGuire; A C Gingras; H Li; H Matsuo; N Sonenberg; G Wagner
Journal:  Biochemistry       Date:  1998-01-06       Impact factor: 3.162

3.  Synthesis of 7-benzylguanosine cap-analogue conjugates for eIF4E targeted degradation.

Authors:  Tanpreet Kaur; Arya Menon; Amanda L Garner
Journal:  Eur J Med Chem       Date:  2019-01-31       Impact factor: 6.514

4.  Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.

Authors:  Erin E Gallagher; James M Song; Arya Menon; Lauren D Mishra; Alyah F Chmiel; Amanda L Garner
Journal:  J Med Chem       Date:  2019-05-09       Impact factor: 7.446

5.  In Situ Methylene Capping: A General Strategy for Efficient Stereoretentive Catalytic Olefin Metathesis. The Concept, Methodological Implications, and Applications to Synthesis of Biologically Active Compounds.

Authors:  Chaofan Xu; Xiao Shen; Amir H Hoveyda
Journal:  J Am Chem Soc       Date:  2017-07-27       Impact factor: 15.419

6.  High-Throughput Chemical Probing of Full-Length Protein-Protein Interactions.

Authors:  James M Song; Arya Menon; Dylan C Mitchell; Oleta T Johnson; Amanda L Garner
Journal:  ACS Comb Sci       Date:  2017-11-14       Impact factor: 3.784

7.  Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.

Authors:  Song Yi Ko; Huifang Guo; Nicolas Barengo; Honami Naora
Journal:  Clin Cancer Res       Date:  2009-05-19       Impact factor: 12.531

8.  Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice.

Authors:  S-H Chang; J-E Kim; J-H Lee; A Minai-Tehrani; K Han; C Chae; Y-H Cho; J-H Yun; K Park; Y-S Kim; M-H Cho
Journal:  Cancer Gene Ther       Date:  2013-05-03       Impact factor: 5.987

9.  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Authors:  Yong S Chang; Bradford Graves; Vincent Guerlavais; Christian Tovar; Kathryn Packman; Kwong-Him To; Karen A Olson; Kamala Kesavan; Pranoti Gangurde; Aditi Mukherjee; Theresa Baker; Krzysztof Darlak; Carl Elkin; Zoran Filipovic; Farooq Z Qureshi; Hongliang Cai; Pamela Berry; Eric Feyfant; Xiangguo E Shi; James Horstick; D Allen Annis; Anthony M Manning; Nader Fotouhi; Huw Nash; Lyubomir T Vassilev; Tomi K Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

10.  Crystal structures of stapled and hydrogen bond surrogate peptides targeting a fully buried protein-helix interaction.

Authors:  Christopher H Douse; Sabrina J Maas; Jemima C Thomas; James A Garnett; Yunyun Sun; Ernesto Cota; Edward W Tate
Journal:  ACS Chem Biol       Date:  2014-08-06       Impact factor: 5.100

View more
  2 in total

1.  A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.

Authors:  Erin E Gallagher; Arya Menon; Alyah F Chmiel; Kirsten Deprey; Joshua A Kritzer; Amanda L Garner
Journal:  Eur J Med Chem       Date:  2020-07-25       Impact factor: 6.514

2.  Constrained Peptides with Fine-Tuned Flexibility Inhibit NF-Y Transcription Factor Assembly.

Authors:  Sadasivam Jeganathan; Mathias Wendt; Sebastian Kiehstaller; Diego Brancaccio; Arne Kuepper; Nicole Pospiech; Alfonso Carotenuto; Ettore Novellino; Sven Hennig; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-17       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.